An improved recombineering approach by adding RecA to λ Red recombination
- 1.4k Downloads
Recombineering is the use of homologous recombination in Escherichia coli for DNA engineering. Of several approaches, use of the λ phage Red operon is emerging as the most reliable and flexible. The Red operon includes three components: Redα, a 5′ to 3′ exonuclease, Redβ, an annealing protein, and Redλ, an inhibitor of the major E. coli exonuclease and recombination complex, RecBCD. Most E. coli cloning hosts are recA deficient to eliminate recombination and therefore enhance thestabulity of cloned DNAs. However, loss of RecA also impairs general cellular integrity. Here we report that transient RecA co-expression enhances the total numer of successful recombinations in bacterial artificial chromosomes (BACs), mostly because the E. coli host is more able to survive the stresses of DNA transformation procedures. We combined this practical improvement with the advantages of a temperature-sensitive version of the low copy pSC 101 plasmid to develop a protocol that is convenient and more efficient than any recombineering procedure, for use of either double-or single-stranded DNA, published to date.
Index EntriesRecombineering Red/ET recA λ red counter selection BAC
Unable to display preview. Download preview PDF.
- 15.Poteete, A. R. (2001) What makes the bacteriophage λ Red system useful for genetic engineering: molecular mechanism and biological function. FEMS Microbio. Lett. 201, 9–14.Google Scholar
- 24.Muyrers, J. P. P., Zhang, Y., Buchholz, F., and Stewart, A. F. (2000) RecE/RecT and Redα/Redβ initiate doublestranded break repair by specifically interacting with their respective partners. Genes & Dev. 14, 1971–1982.Google Scholar
- 30.Walker, G. C. (1996) The SOS response of Escherichia coli in Escherichia coli and Salmonella (Neidhardt, F. C., ed.). Washington, ASM Press.Google Scholar
- 33.Reyrat, J. M., Pelicic, V., Gicquel, B., and Rappuoli, R. (1998) Counterselectable markers: untapped tools for bacterial genetics and pathogenesis. Infect. Immunol. 66, 4011–4017.Google Scholar